Clinical Trial

Belzutifan VHL RCC HK Prospective Registry

Name: Belzutifan VHL RCC HK Prospective Registry — clinical trial record (NCT07554508)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the Belzutifan's efficacy, drug safety, disease course, and the health-economic impact of the treatment to Von Hippel-Lindau (VHL) syndrome.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-04-21.

Trial Details

NCT Number	NCT07554508
Lead Sponsor	Chinese University of Hong Kong
Conditions	VHL - Von Hippel-Lindau Syndrome
Enrollment	100 participants
Start Date	2026-05
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-05